In a bid to bolster clinical research efforts across India, the Indian Council of Medical Research (ICMR) has announced a call for expressions of interest (EOI) to expand the Indian Clinical Trial and Education Network (INTENT). INTENT, established by the ICMR, serves as a collaborative platform for medical colleges, hospitals, and research institutes aimed at conducting scientifically rigorous clinical trials addressing critical health issues.
BENGALURU, May 6 (Reuters) - Indian generic drugmaker Lupin (LUPN.NS), opens new tab reported a smaller-than-expected rise in fourth-quarter profit on Monday, as higher raw material costs more than offset strong demand for its drugs in North America and domestic markets.
Zydus Lifesciences subsidiary Sentynl Therapeutics has announced the worldwide acquisition of the Zokinvy (lonafarnib) programme from Eiger BioPharmaceuticals for the treatment of progeria.
Quadria Capital invests $102M in NephroPlus, Asias largest dialysis network, acquiring a minority stake. NephroPlus serves dialysis demand in India & fast-growing markets. CEO Vuppala aims for expansion. Cochin International Airport Ltd (Cial) responded to a surge in domestic passengers by increasing services.
Key to its effectiveness is that the specific virus regions the vaccine targets also appear in many related coronaviruses. By training the immune system to attack these regions, it gives protection against other coronaviruses not represented in the vaccine, including ones that haven't even been identified yet
Vaccine manufacturer Serum Institute of India (SSI) has filed a challenge to the Supreme Court against a 2016 amendment to the Income Tax Act that made subsidies, grants, waivers, concessions, or reimbursements by the Centre or states or incentives in cash or kind as taxable.19 hours ago
Caplin Point Laboratories Limited has received Colombia's INVIMA approval for its Softgel Capsules division at Puducherry. The site inspection of Unit-1 was completed on May 3rd and found compliant as per INVlMA's norms of Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP).
Dr. Reddy's Laboratories Ltd. announced its launch of Doxycycline Capsules, 40 mg in the U.S. market, a therapeutic generic equivalent of ORACEA® (doxycycline, USP) Capsules, 40 mg approved by the U.S. Food and Drug Administration (USFDA).
Suven Life Sciences Limited has reported consolidated financial results for the period ended March 31, 2024.